¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"effective alveolar ventilation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective alveolar ventilation
    1. À¯È¿ÆóÆ÷ȯ±â 2. À¯È¿ÆóÆ÷ȯ±â·®
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alveolar ventilation
    ÆóÆ÷ȯ±â, ÇãÆÄ²Ê¸®È¯±â
  • alveolar ventilation rate
    ÆóÆ÷ȯ±âÀ², ÇãÆÄ²Ê¸®È¯±âÀ²
  • biologically effective dose
    »ý¹°ÇÐÀûÀ¯È¿¼±·®
  • collective effective dose
    Áý´ÜÀ¯È¿¼±·®
  • committed effective dose
    ¿¹Å¹À¯È¿¼±·®
  • effective capacity
    À¯È¿¿ëÀû
  • effective charge
    À¯È¿ÀüÇÏ
  • effective chlorine
    À¯È¿¿°¼Ò
  • effective circulating volume
    À¯È¿¼øÈ¯¿ëÀû
  • effective current
    À¯È¿Àü·ù
  • effective demand
    À¯È¿¼ö¿ä
  • effective dose
    1. À¯È¿¿ë·® 2. À¯È¿¼±·®
  • effective dose equivalent
    À¯È¿¼±·®ÇØ´ç·®
  • effective filtration pressure
    À¯È¿¿©°ú¾Ð, À¯È¿°Å¸£±â¾Ð
  • effective mass
    À¯È¿Áú·®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alveolar ventilation rate
    ÇãÆÄ²Ê¸®È¯±âÀ², ÆóÆ÷ȯ±âºñ
  • alveolar ventilation
    ÆóÆ÷ȯ±â, ÇãÆÄ²Ê¸®È¯±â
  • effective dose
    À¯È¿¿ë·®, À¯È¿¼±·®
  • effective demand
    À¯È¿¼ö¿ä
  • effective blood volume
    À¯È¿Ç÷¾×·®
  • ventilation
    ȯ±â
  • dead space ventilation
    Á×Àº°ø°£È¯±â, »ç°­È¯±â
  • noninvasive positive-pressure ventilation
    ºñħ½À¾ç¾Ðȯ±â
  • pressure-controlled ventilation
    ¾Ð·ÂÁ¶Àýȯ±â
  • alveolar bone
    ÀÌÆ²»À
  • alveolar cleft
    ÀÌÆ²Æ´»õ, Ä¡Á¶¿­
  • alveolar duct
    ÆóÆ÷°ü, ÇãÆÄ²Ê¸®°ü
  • alveolar hypoventilation
    ÆóÆ÷Àúȯ±â, ÇãÆÄ²Ê¸®Àúȯ±â
  • alveolar macrophage
    ²Ê¸®Å«Æ÷½Ä¼¼Æ÷, ÆóÆ÷´ë½Ä¼¼Æ÷
  • alveolar structure
    ²Ê¸®±¸Á¶, ÆóÆ÷±¸Á¶
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective alveolar ventilation
    À¯È¿ÆóÆ÷ȯ±â, À¯È¿ÆóÆ÷ȯ±â·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alveolar ventilation
    ÆóÆ÷ȯ±â, ÇãÆÄ²Ê¸®È¯±â
  • alveolar ventilation rate
    ÇãÆÄ²Ê¸®È¯±âÀ², ÆóÆ÷ȯ±âºñ
  • biologically effective dose
    »ý¹°ÇÐÀûÀ¯È¿¼±·®
  • collective effective dose
    Áý´ÜÀ¯È¿¼±·®
  • committed effective dose
    ¿¹Å¹À¯È¿¼±·®
  • effective capacity
    À¯È¿¿ë·®
  • effective charge
    À¯È¿ÀüÇÏ
  • effective chlorine
    À¯È¿¿°¼Ò
  • effective current
    À¯È¿Àü·ù
  • effective temperature chart
    °¨°¢¿ÂµµÇ¥
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
  • effective demand
    À¯È¿¼ö¿ä
  • effective dose
    À¯È¿¿ë·®, À¯È¿¼±·®
  • individual effective dose
    °³ÀÎÀ¯È¿¿ë·®
  • mean effective dose
    Æò±ÕÀ¯È¿¼±·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • EAV=£¾effective alveolar ventilation
    À¯È¿ÆóÆ÷ȯ±â(·®).
  • VA => alveolar ventilation
    ÆóÆ÷ȯ±â
  • alveolar ventilation
    ÆóÆ÷ȯ±â(·®)
  • alveolar ventilation rate
    ÆóÆ÷ȯ±âºñ(¡­üµÑ¨Ýï)
  • alveolar ventilation volume
    ÆóÆ÷ȯ±â¿ëÀû
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®, Áß°£À¯È¿·®.
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®.
  • ELBF=£¾effective liver blood flow
    À¯È¿¼º °£Ç÷·ù.
  • ELBF=£¾effective liver blood flow
    À¯È¿ °£Ç÷·ù.
  • EPNDB =effective perceived noise level
    ½ÇÈ¿°¨¼ö¼ÒÀ½·¹º§, ½ÇÁ¦°¨°¢¼ÒÀ½
  • ERPF => effective renal plasma flow
    À¯È¿½ÅÇ÷ÀåÀ¯Åë·®
  • ERPF=£¾effective renal plasma flow
    À¯È¿½ÅÇ÷·ù·®.
  • MED => minimum effective dose
    ÃÖ¼ÒÈ«¹Ý·®
  • MED=> minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • MED=£¾minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective alveolar ventilation =EAV
    À¯È¿ÆóÆ÷ȯ±â(·®)(êóüùøËøàüµÑ¨åÖ) .
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective alveolar air
    À¯È¿ÆóÆ÷°ø±â(êóüùøËøàÍöѨ).
  • alveolar ventilation
    ÆóÆ÷ȯ±â(·®)
  • alveolar ventilation rate
    ÆóÆ÷ȯ±âºñ(¡­üµÑ¨Ýï)
  • alveolar ventilation volume
    ÆóÆ÷ȯ±â¿ëÀû
  • maximal alveolar ventilation
    ÃÖ´ëÆóÆ÷ȯ±â·®.
  • minute alveolar ventilation
    ºÐ´çÆóÆ÷ȯ±â·®(ÝÂÓØøËøàüµÑ¨åÖ).
  • biologically effective dose
    »ý¹°ÇÐÀûÀ¯È¿¼±·®
  • collective effective dose
    Áý´ÜÀ¯È¿¼±·®
  • committed effective dose
    ¿¹Å¹À¯È¿¼±·®
  • committed effective dose equivalent
    ¿¹Å¹À¯È¿¼±·®´ç·®
  • effective TR
    À¯È¿ ¹Ýº¹ ½Ã°£
  • effective blood volume
    À¯È¿Ç÷¾×·®(êóüùúìäûÕá).
  • effective blood volume
    À¯È¿Ç÷¾×·®.
  • effective capacity
    À¯È¿¿ë·®.
  • effective charge
    À¯È¿ÀüÇÏ(¡­ï³ùÃ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Alveolar duct
    ²Ê¸®°ü
    [¿¾ ¿ë¾î] ÆóÆ÷°ü
  • Alveolar gland
    ²Ê¸®»ù
    [¿¾ ¿ë¾î] Æ÷»ó¼±
  • Alveolar period
    ²Ê¸®½Ã±â
    [¿¾ ¿ë¾î] ÆóÆ÷±â
  • Alveolar bud
    ²Ê¸®½Ï
    [¿¾ ¿ë¾î] ÆóÆ÷·Ú
  • Alveolar terminal portion
    ²Ê¸®Á¾¸»ºÎÀ§
    [¿¾ ¿ë¾î] Æ÷»óÁ¾¸»ºÎ
  • Alveolar sac
    ²Ê¸®ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÆóÆ÷³¶
  • Tubulo-alveolar gland
    ´ë·Õ²Ê¸®»ù
    [¿¾ ¿ë¾î] °üÆ÷»ó¼±
  • Posterior superior alveolar branches
    µÚÀ§ÀÌÆ²°¡Áö
    [¿¾ ¿ë¾î] ÈÄ»óÄ¡Á¶Áö
  • Posterior superior alveolar artery
    µÚÀ§ÀÌÆ²µ¿¸Æ
    [¿¾ ¿ë¾î] ÈÄ»óÄ¡Á¶µ¿¸Æ
  • Inferior alveolar artery
    ¾Æ·¡ÀÌÆ²µ¿¸Æ
    [¿¾ ¿ë¾î] ÇÏÄ¡Á¶µ¿¸Æ
  • Inferior alveolar nerve
    ¾Æ·¡ÀÌÆ²½Å°æ
    [¿¾ ¿ë¾î] ÇÏÄ¡Á¶½Å°æ
  • Anterior superior alveolar branches
    ¾ÕÀ§ÀÌÆ²°¡Áö
    [¿¾ ¿ë¾î] Àü»óÄ¡Á¶Áö
  • Anterior superior alveolar arteries
    ¾ÕÀ§ÀÌÆ²µ¿¸Æ
    [¿¾ ¿ë¾î] Àü»óÄ¡Á¶µ¿¸Æ
  • Superior alveolar nerves
    À§ÀÌÆ²½Å°æ
    [¿¾ ¿ë¾î] »óÄ¡Á¶½Å°æ
  • Alveolar canal
    ÀÌÆ²°ü
    [¿¾ ¿ë¾î] Ä¡Á¶°ü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alveolar hydatid cyst
    ´Ù¹æÆ÷Ãæ
  • alveolar hydatidosis
    ´Ù¹æÆ÷ÃæÁõ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective concentration
    À¯È¿ ³óµµ (êóüùÒØÓø)
  • effective half-life
    À¯È¿ ¹Ý°¨±â(êóüùÚâÊõÑ¢)
  • effective lethal phase
    À¯È¿ Ä¡»ç±â(êóüùöÈÞÝÑ¢)
  • median effective dose
    Á¤Áß À¯È¿·®(ïáñéêóüùÕá)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intermittent positive pressure ventilation
    °£ÇæÀû¾ç¾Ðȯ±â¹ý
  • ventilation
    Åëdz, ȯ±â
  • effective half life
    À¯È¿¹Ý°¨±â
  • effective TR
    À¯È¿¹Ýº¹½Ã°£
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • alveolar
    Ä¡Á¶ÆóÆ÷¼º, ÆóÆ÷ÀÇ
  • alveolar bone
    Ä¡Á¶°ñ
  • alveolar cancer
    Æ÷»ó¾Ï
  • alveolar cell carcinoma
    ÆóÆ÷¼¼Æ÷¾ÏÁ¾
  • alveolar duct
    ÆóÆ÷°ü
  • alveolar flooding
    ÆóÆ÷È«¼ö
  • alveolar pattern
    ÆóÆ÷¾ç»ó
  • alveolar sac
    ÆóÆ÷³¶
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CMV continuous mandatory ventilation; controlled mechanical ventilation; conventional mechanical ventila...
AERP antegrade effective refractory period; atrial effective refractory period
ESP early systolic paradox; echo spacing; effective sensory projection; effective systolic pressure; end...
MEC median effective concentration; middle ear canal; middle ear cell; minimum effective concentration
AD accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ACCESS Access to Community Care and Effective Services and Support
AERP Atrial effective refractory period
BED Biologically Effective Dose
ED50 Effective Dose
ED50 Effective Dose 50
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • independent lung ventilation
    ºÐ¸® Æóȯ±â ¸¶Ãë
  • jet ventilation
    Á¦Æ® ȯ±â
  • natural ventilation
    ÀÚ¿¬ ȯ±â
  • ventilation drive
    ȯ±â ±¸µ¿
  • ventilation perfusion ratio
    ȯ±âÀ²
  • window gravity ventilation
    â¹® Á߷ ȯ±â
  • committed effective dose equivalent
    ¿¹Å¹ À¯È¿ ¼±·® ´ç·®
  • effective
    À¯È¿ÇÑ
    ÀǵµµÈ °á°ú¸¦ ÀÏÀ¸Å³ ¼ö ÀÖ´Â.
  • effective arterial volume
    À¯È¿ µ¿¸ÆÇ÷·®
  • effective blood volume
    À¯È¿ Ç÷¾×·®
  • effective diameter
    À¯È¿ Áö¸§
  • effective dose 50%
    Áß°£ À¯È¿·®, 50% À¯È¿·®
    µ¿¹°¿¡ µ¶¼Ò³ª ¾à¹° Åõ¿© ½Ã, 50%ÀÇ µ¿¹°¿¡¼­ À¯È¿ÇÏ´Ù°í ÃßÁ¤µÇ´Â ¿ë·®.
  • effective focal spot
    ½ÇÈ¿ ÃÊÁ¡
  • effective mass
    À¯È¿ Áú·®
  • effective osmolality
    À¯È¿ »ïÅõÁú ³óµµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
alveolar ventilation The volume of gas expired from the alveoli to the outside of the body per minute; calculated as the respiratory frequency (f) multiplied by the difference between tidal volume and the dead space (VT -VD); units: ml/min BTPS.
(05 Mar 2000)
aperture, effective <microscopy> The diameter of the entrance pupil: it is the apparent diameter of the limiting aperture measured from the front.
(05 Aug 1998)
renal blood flow, effective The amount of blood flowing to the parts of the kidney that are involved with the production of constituents of urine. It is that portion of the total renal blood flow that perfuses functional renal tissue (e.g., the glomeruli). It should be differentiated from renal plasma flow, effective which is based on the amount of plasma rather than on total renal blood.
(12 Dec 1998)
median effective dose The dose that produces the desired effect; when followed by a subscript (generally "ED50"), it denotes the dose having such an effect on a certain percentage (e.g., 50%) of the test animals; ED50 is the median effective dose, in radiation protection, the sum of the equivalent doses in all tissues and organs of the body weighted for tissue effects of radiation. The unit of effective dose is the sievert (Sv), epilation dose, the minimum amount of radiation sufficient to produce hair loss, usually in 10 to 14 days.
(05 Mar 2000)
cost-effective A term describing a resource that is available within the time it is needed and is able to meet or reduce electrical power demand at an estimated incremental system cost no greater than that of the least-costly, similarly reliable and available alternative.
(05 Dec 1998)
effective Producing the intended result.
(18 Nov 1997)
effective collision radius <radiobiology> Effective size of a particle equal to the square root of (cross-section/pi). Determines the effective range of interaction of the particle.
(09 Oct 1997)
effective conjugate The internal conjugate measured from the nearest lumbar vertebra to the symphysis, in spondylolisthesis.
Synonym: false conjugate.
(05 Mar 2000)
effective dose The dose that produces the desired effect; when followed by a subscript (generally "ED50"), it denotes the dose having such an effect on a certain percentage (e.g., 50%) of the test animals; ED50 is the median effective dose, in radiation protection, the sum of the equivalent doses in all tissues and organs of the body weighted for tissue effects of radiation. The unit of effective dose is the sievert (Sv), epilation dose, the minimum amount of radiation sufficient to produce hair loss, usually in 10 to 14 days.
(05 Mar 2000)
effective half-life <radiobiology> Time required for a radioactive substance contained in a biological system (such as a person or an animal) to reduce its radioactivity by half, as a combination result of radioactive decay and biological elimination from the system.
(09 Oct 1997)
effective osmotic pressure That part of the total osmotic pressure of a solution that governs the tendency of its solvent to pass across a boundary, usually a semipermeable membrane; it is commonly represented by the product of the total osmotic pressure of the solution and the ratio (corrected for activities) of the number of dissolved particles that do not permeate the bounding membrane to the total number of particles in the solution; equivalent in meaning to tonicity; commonly expressed in equivalent units of osmolality rather than pressure per se.
(05 Mar 2000)
effective refractory period The period during which impulses may appear but are too weak to be conducted; the longest interval between adequate stimuli, falling just short of the time necessary to allow a propagated response to be evoked in a tissue by the second stimulus; it differs from the functional refractory period in that it is a measure of stimulus interval rather than response interval of time.
(05 Mar 2000)
effective renal blood flow The amount of blood flowing to the parts of the kidney that are involved with production of constituents of urine.
(05 Mar 2000)
effective renal plasma flow <physiology> The amount of plasma flowing to the parts of the kidney that have a function in the production of constituents of urine; the clearance of substances such as iodopyracet and p-aminohippuric acid, assuming that the extraction ratio in the peritubular capillaries is 100%.
It is the amount of plasma perfusing the kidney tubules per unit time, generally measured by p-aminohippurate clearance. It should be differentiated from renal plasma flow which is approximately 10% greater than the effective renal plasma flow.
(07 Mar 2000)
effective temperature A comfort index or scale which takes into account the temperature of air, its moisture content, and movement.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alveolar
    ÆóÆ÷ÀÇ;Ä¡Á¶ÀÇ;Ä¡Á¶À½
  • ventilation
    ȯ±â
  • ventilation
    °ø±âÀÇ À¯Åë;Åëdz;ȯ±â;Åëdz»óÅÂ;ȯ±â¹ý;ȯ±â ÀåÄ¡;ÀÚÀ¯ ÅäÀÇ;¹®Á¦ÀÇ °ø°³ Åä·Ð;¿©·Ð¿¡ ¹¯±â;(Àǰß,°¨Á¤ µîÀÇ)¹Ù·Î;Ç¥Ãâ
  • effective
    È¿°úÀûÀÎ
  • cost-effective
    ºñ¿ëÈ¿À²ÀûÀÎ
  • effective
    À¯È¿ÇÑ;È¿°úÀûÀÎ;ÀλóÀûÀÎ;»ç½Ç»óÀÇ;½ÇÁ¦ÀÇ;È¿·ÂÀÖ´Â;µ¿¿ø°¡´ÉÇÑ;º´·Â;´«¿¡ ¶ç´Â
  • effective aperture
    (±¤)(·»ÁîÀÇ) À¯È¿ ±¸°æ
  • effective demand
    (°æ)À¯È¿ ¼ö¿ä
  • effective exchange rate
    (±ÝÀ¶)½ÇÈ¿ ȯ½Ã¼¼(ȯÀ²)(±¹Á¦ÅëÈ­±â±ÝÀÌ ´çÇØ±¹°ú ´Ù¸¥ ÁÖ¿ä 20°³±¹ ÅëÈ­ÀÇ È¯½Ã¼¼¸¦ º¹ÇÕ½ÃÄÑ »êÃâÇÏ´Â Áö¼ö)
  • effective money (coin)
    °æÈ­
  • effective range
    (°ø)À¯È¿ »ç°Å¸®(»çÁ¤)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á